Close Asset Management’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.19M | Sell |
37,440
-100
| -0.3% | -$8.91K | 0.09% | 61 |
|
|
2025
Q4 | $2.97M | Sell |
37,540
-3,928
| -9% | -$308K | 0.07% | 64 |
|
|
2025
Q3 | $3.31M | Buy |
41,468
+304
| +0.7% | +$25.9K | 0.07% | 63 |
|
|
2025
Q2 | $3.74M | Buy |
41,164
+200
| +0.5% | +$18.3K | 0.11% | 60 |
|
|
2025
Q1 | $3.84M | Sell |
40,964
-395
| -1% | -$35.4K | 0.11% | 55 |
|
|
2024
Q4 | $3.76M | Hold |
41,359
| – | – | 0.11% | 55 |
|
|
2024
Q3 | $4.29M | Sell |
41,359
-4,420
| -10% | -$450K | 0.13% | 55 |
|
|
2024
Q2 | $4.44M | Buy |
45,779
+1,101
| +2% | +$102K | 0.15% | 55 |
|
|
2024
Q1 | $4.02M | Buy |
44,678
+350
| +0.8% | +$29.7K | 0.15% | 55 |
|
|
2023
Q4 | $3.53M | Buy |
44,328
+2,740
| +7% | +$206K | 0.15% | 54 |
|
|
2023
Q3 | $2.96M | Buy |
41,588
+268
| +0.6% | +$20K | 0.15% | 55 |
|
|
2023
Q2 | $3.18M | Sell |
41,320
-525
| -1% | -$40.6K | 0.15% | 53 |
|
|
2023
Q1 | $3.14M | Sell |
41,845
-10,030
| -19% | -$746K | 0.16% | 51 |
|
|
2022
Q4 | $4.09M | Buy |
51,875
+300
| +0.6% | +$22.5K | 0.22% | 40 |
|
|
2022
Q3 | $3.63M | Hold |
51,575
| – | – | 0.21% | 41 |
|
|
2022
Q2 | $4.13M | Sell |
51,575
-4,645
| -8% | -$363K | 0.2% | 42 |
|
|
2022
Q1 | $4.8M | Hold |
56,220
| – | – | 0.17% | 38 |
|
|
2021
Q4 | $4.8M | Sell |
56,220
-2,481
| -4% | -$194K | 0.17% | 38 |
|
|
2021
Q3 | $4.44M | Buy |
58,701
+7,080
| +14% | +$562K | 0.22% | 34 |
|
|
2021
Q2 | $4.2M | Hold |
51,621
| – | – | 0.2% | 38 |
|
|
2021
Q1 | $4.07M | Sell |
51,621
-4,945
| -9% | -$388K | 0.22% | 42 |
|
|
2020
Q4 | $4.83M | Sell |
56,566
-465
| -0.8% | -$38.5K | 0.36% | 31 |
|
|
2020
Q3 | $4.4M | Buy |
57,031
+50
| +0.1% | +$3.81K | 0.3% | 33 |
|
|
2020
Q2 | $4.17M | Buy |
56,981
+4,285
| +8% | +$304K | 0.31% | 32 |
|
|
2020
Q1 | $3.5M | Sell |
52,696
-4,124
| -7% | -$291K | 0.31% | 31 |
|
|
2019
Q4 | $3.91M | Sell |
56,820
-900
| -2% | -$61.4K | 0.31% | 37 |
|
|
2019
Q3 | $4.24M | Sell |
57,720
-270
| -0.5% | -$19.6K | 0.37% | 36 |
|
|
2019
Q2 | $4.15M | Buy |
57,990
+6,790
| +13% | +$482K | 0.32% | 37 |
|
|
2019
Q1 | $3.51M | Buy |
51,200
+50,925
| +18,518% | +$3.29M | 0.3% | 37 |
|
|
2018
Q4 | $9K | Sell |
275
-56,955
| -100% | -$3.56M | ﹤0.01% | 159 |
|
|
2018
Q3 | $3.4M | Sell |
57,230
-4,785
| -8% | -$319K | 0.27% | 42 |
|
|
2018
Q2 | $4.35M | Hold |
62,015
| – | – | 0.37% | 32 |
|
|
2018
Q1 | $4.35M | Sell |
62,015
-3,230
| -5% | -$232K | 0.35% | 33 |
|
|
2017
Q4 | $4.93M | Buy |
65,245
+325
| +0.5% | +$23.7K | 0.44% | 32 |
|
|
2017
Q3 | $4.73M | Buy |
64,920
+265
| +0.4% | +$19.1K | 0.47% | 32 |
|
|
2017
Q2 | $4.79M | Buy |
64,655
+19,455
| +43% | +$1.44M | 0.53% | 32 |
|
|
2017
Q1 | $3.31M | Buy |
45,200
+29,775
| +193% | +$2.08M | 0.35% | 37 |
|
|
2016
Q4 | $1.01M | Buy |
+15,425
| New | +$1.06M | 0.15% | 48 |
|
Other funds holding CL
VCM
DAM
VPM
Close Asset Management's CL Position: Q1 2026 in Review
Close Asset Management reduced its Colgate-Palmolive (CL) stake by 0.27% in Q1 2026, selling an estimated $8.91K and leaving 37,440 shares worth $3.19M. The position accounts for 0.09% of the portfolio, ranked #61.
Close Asset Management first reported a position in CL in Q4 2016 and has held it in 38 quarters since. The position peaked at $4.93M in Q4 2017. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- Close Asset Management held 37,440 shares of Colgate-Palmolive worth $3.19M as of Q1 2026.
- Close Asset Management sold 100 Colgate-Palmolive shares in Q1 2026, an estimated $8.91K.
- Colgate-Palmolive made up 0.09% of Close Asset Management's portfolio in Q1 2026, its #61 holding.
- Close Asset Management first reported a position in Colgate-Palmolive in Q4 2016 and has held it in 38 quarters since.
- Close Asset Management's Colgate-Palmolive position peaked at $4.93M in Q4 2017.
- 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on Close Asset Management's 13F filing for Q1 2026, filed 12 May 2026.